Dowsett M - Search Results

1

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.

Dowsett M, Nielsen TO, A'Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, McShane L, Paik S, Penault-Llorca F, Prudkin L, Regan M, Salter J, Sotiriou C, Smith IE, Viale G, Zujewski JA, Hayes DF; International Ki-67 in Breast Cancer Working Group. Dowsett M, et al. J Natl Cancer Inst. 2011 Nov 16;103(22):1656-64. doi: 10.1093/jnci/djr393. Epub 2011 Sep 29. J Natl Cancer Inst. 2011. PMID: 21960707 Free PMC article.

2

Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.

Dowsett M, Stein RC, Coombes RC. Dowsett M, et al. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):155-9. doi: 10.1016/0960-0760(92)90201-s. J Steroid Biochem Mol Biol. 1992. PMID: 1388047 Review.

3

Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention.

Harper-Wynne C, Ross G, Sacks N, Salter J, Nasiri N, Iqbal J, A'Hern R, Dowsett M. Harper-Wynne C, et al. Among authors: dowsett m. Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):614-21. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12101108 Clinical Trial.

4

Current status of HER2 testing.

Di Leo A, Dowsett M, Horten B, Penault-Llorca F. Di Leo A, et al. Among authors: dowsett m. Oncology. 2002;63 Suppl 1:25-32. doi: 10.1159/000066204. Oncology. 2002. PMID: 12422052 Review.

5

Preoperative models to evaluate endocrine strategies for breast cancer.

Dowsett M. Dowsett M. Clin Cancer Res. 2003 Jan;9(1 Pt 2):502S-10S. Clin Cancer Res. 2003. PMID: 12538507 Review.

6

Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancer.

Johnston SR, Head J, Pancholi S, Detre S, Martin LA, Smith IE, Dowsett M. Johnston SR, et al. Among authors: dowsett m. Clin Cancer Res. 2003 Jan;9(1 Pt 2):524S-32S. Clin Cancer Res. 2003. PMID: 12538510 Review.

7

Aromatase inhibitors in breast cancer.

Smith IE, Dowsett M. Smith IE, et al. Among authors: dowsett m. N Engl J Med. 2003 Jun 12;348(24):2431-42. doi: 10.1056/NEJMra023246. N Engl J Med. 2003. PMID: 12802030 Review. No abstract available.

8

Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer.

Johnston SR, Hickish T, Ellis P, Houston S, Kelland L, Dowsett M, Salter J, Michiels B, Perez-Ruixo JJ, Palmer P, Howes A. Johnston SR, et al. Among authors: dowsett m. J Clin Oncol. 2003 Jul 1;21(13):2492-9. doi: 10.1200/JCO.2003.10.064. J Clin Oncol. 2003. PMID: 12829668 Clinical Trial.

9

Role of biologic markers in patient selection and application to disease prevention.

Dowsett M, Ellis MJ. Dowsett M, et al. Am J Clin Oncol. 2003 Aug;26(4):S34-9. doi: 10.1097/00000421-200308001-00006. Am J Clin Oncol. 2003. PMID: 12902875

10

Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells.

Zabaglo L, Ormerod MG, Parton M, Ring A, Smith IE, Dowsett M. Zabaglo L, et al. Among authors: dowsett m. Cytometry A. 2003 Oct;55(2):102-8. doi: 10.1002/cyto.a.10071. Cytometry A. 2003. PMID: 14505315 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters